(2026). Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling. FEBS Open Bio.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Pharmacological Inhibition of the PERK Pathway Modulates Hepatocellular Carcinoma Growth and Immune Signaling."
FEBS Open Bio 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Pharmacological Inhibition of the PERK Pathway Modulates Hepatocellular Carcinoma Growth and Immune Signaling."
FEBS Open Bio, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.